Validated Stability-indicating Assay Method for Determination of Ilaprazole in Bulk Drug and Tablets by High Performance Liquid Chromatography
 
More details
Hide details
1
Department of P’ceutical Analysis, P. Wadhwani College of Pharmacy, Yavatmal, India
2
Department of Pharmacology, P. Wadhwani College of Pharmacy, Yavatmal, India
CORRESPONDING AUTHOR
Pradeep G. Shelke   

Department of P’ceutical Analysis, P. Wadhwani College of Pharmacy, Yavatmal, India
Publication date: 2017-10-05
 
Eurasian J Anal Chem 2015;10(1):1–9
 
KEYWORDS
ABSTRACT
A validated stability-indicating HPLC method has been reported for the determination of Ilaprazole in bulk drug and tablet. The drug was subjected to the various stress conditions as per the ICH guidelines. The degradation behavior of Ilaprazole was studied under hydrolytic, oxidative, photolytic and thermal conditions and was found to be unstable in almost all conditions except under alkaline and photolytic conditions. The separation of drug and its degraded products was carried out on Kinetex C-18 100A (5µ, 250×4.6 mm) column. The initial mobile phase composition used was Acetonitrile and water in the ratio 50:70v/v for 1 min then changed to 70:30v/v in next 6 min and finally equilibrated back to initial composition in 14min. The method was applied for the determination of Ilaprazole in marketed tablet formulation. The detection was carried at 305 nm using PDA detector with a flow rate of 1.0ml/min and injection volume 20µl. The validation of developed method was performed for linearity, accuracy, precision, selectivity and specificity and robustness.
 
REFERENCES (8)
1.
International Conference on Harmonization (2000) Stability testing of new drug substances and products (Q1AR). Geneva, Switzerland: International Conference on Harmonization.
 
2.
International Conference on Harmonization 1(993) Stability testing of new drug substances and products (Q1AR). Geneva, Switzerland: International Conference on Harmonization.
 
3.
Bakshi M, Singh S (2002) Development of validated stability –indicating assay methods-critical review. J Pharm Biomed Anal;28:1011-40.
 
4.
International Conference on Harmonization (1999) Specifications: Test procedures and acceptance criteria for new drug substances and new drug products: chemical substances. Geneva, Switzerland: International Conference on Harmonization.
 
5.
Satheesh B, Ganesh KK, Sarvanan D, Ramakant KG, Sivanathan S (2013) Simultaneous determination of ilaprazole and its related compounds in pharmaceutical dosage forms by UPLC. J Liq Chromatogr Related Technol;36:2968-81.
 
6.
Zhi-rong T, Yi-cheng W, Yao C, Dong G, Shan C, Wei Z (2012) Development and validation of a LC-MS/MS method for the determination of Ilaprazole enantiomers and its application to a Bioequivalence study in healthy Chinese volunteers.Chromatogr;75: 95-01.
 
7.
Zhou G, Shi S, Zhang W, Tan Z, Chen Y, Guo D (2009) An improved LC-MS/MS method for quantitative determination of ilaprazole and its metabolites in human plasma and its application to a pharmacokinetic study. Acta Pharmacol Sin 30(9):1330-6.
 
8.
Zhou G, Shuyun S, Wei Z, Zhirong T, Yao C, Dong G (2010) Identification of ilaprazole metabolites in human urine by HPLC-ESI-MS/MS and HPLC-NMR experiments. Biomed Chromatogr 24:1130-5.
 
eISSN:1306-3057